Bioventus Inc.
BVS
$8.61
$0.101.12%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.48M | 22.73M | 7.59M | -731.00K | -33.87M |
| Total Depreciation and Amortization | 20.64M | 21.30M | 17.30M | 18.18M | 19.22M |
| Total Amortization of Deferred Charges | 3.63M | 3.63M | 5.58M | 5.58M | 5.58M |
| Total Other Non-Cash Items | 43.00M | 40.85M | 47.71M | 46.51M | 62.77M |
| Change in Net Operating Assets | 7.19M | -13.84M | -22.16M | -33.29M | -28.22M |
| Cash from Operations | 102.94M | 74.67M | 56.03M | 36.25M | 25.47M |
| Capital Expenditure | -2.31M | -2.56M | -2.56M | -2.15M | -1.54M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -686.00K | -686.00K | 23.99M | 23.99M | 24.68M |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -3.00M | -3.25M | 21.44M | 21.85M | 23.14M |
| Total Debt Issued | 61.91M | 76.91M | 76.91M | 15.00M | 15.00M |
| Total Debt Repaid | -71.05M | -54.05M | -73.57M | -58.26M | -61.53M |
| Issuance of Common Stock | 2.04M | 2.07M | 2.67M | 3.12M | 2.42M |
| Repurchase of Common Stock | -1.05M | -9.00K | -9.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.08M | -87.06M | -82.55M | -16.07M | -5.28M |
| Cash from Financing | -86.23M | -62.14M | -76.55M | -56.21M | -49.39M |
| Foreign Exchange rate Adjustments | -667.00K | 371.00K | -1.83M | -965.00K | -1.59M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.04M | 9.66M | -910.00K | 916.00K | -2.37M |